Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines.
Publication/Presentation Date
8-1-2014
Abstract
The NCCN Guidelines for Pancreatic Adenocarcinoma discuss the diagnosis and management of adenocarcinomas of the exocrine pancreas and are intended to assist with clinical decision-making. These NCCN Guidelines Insights summarize major discussion points from the 2014 NCCN Pancreatic Adenocarcinoma Panel meeting. The panel discussion focused mainly on the management of borderline resectable and locally advanced disease. In particular, the panel discussed the definition of borderline resectable disease, role of neoadjuvant therapy in borderline disease, role of chemoradiation in locally advanced disease, and potential role of newer, more active chemotherapy regimens in both settings.
Volume
12
Issue
8
First Page
1083
Last Page
1093
ISSN
1540-1413
Published In/Presented At
Tempero, M. A., Malafa, M. P., Behrman, S. W., Benson, A. B., 3rd, Casper, E. S., Chiorean, E. G., Chung, V., Cohen, S. J., Czito, B., Engebretson, A., Feng, M., Hawkins, W. G., Herman, J., Hoffman, J. P., Ko, A., Komanduri, S., Koong, A., Lowy, A. M., Ma, W. W., Merchant, N. B., … Freedman-Cass, D. A. (2014). Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines. Journal of the National Comprehensive Cancer Network : JNCCN, 12(8), 1083–1093. https://doi.org/10.6004/jnccn.2014.0106
Disciplines
Medicine and Health Sciences
PubMedID
25099441
Department(s)
Hematology-Medical Oncology Division
Document Type
Article